Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease

被引:7
作者
Arnott, IDR [1 ]
Drummond, HE [1 ]
Ghosh, S [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Dept Med Sci, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1177/003693300104600504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment goal in Crohns disease is clinical remission, not complete mucosal healing. The incidence of mucosal inflammation in Crohns disease patients in clinical remission is not known. Whole gut lavage is an objective method of assessing mucosal inflammation. We aimed to assess levels of mucosal inflammatory activity in a group of patients with clinically inactive Crohns disease. We prospectively assessed 30 patients with inactive Crohn disease and 28 controls. Inactive disease was defined as Crohns disease activity index of less than 150. All underwent whole put lavage, with analysis of whole gut lavage fluid IgG, haemoglobin, interleukin-1 beta interleukin-8 and granulocyte elastase. Serum inflammatory parameters were collected for comparison. Of the 30 patients with Crohns disease, 10 (33%) had an abnormal immunoglobulin G, 21 (70%) had an elevated interleukin-Ig 20 (66%,) interleukin-8 and 10 (33%) granulocyte elastase in the whole gut lavage fluid. 58% of patients had either 1 or 2 abnormal results. In contrast only 10% had 1 or 2 abnormal serum results. Few abnormalities were present in lavage fluid or serum of the control population. We concluded that ongoing mucosal inflammation is detectable in whole gut lavage fluid of up to 2/3 of Crohns disease patients in clinical remission.
引用
收藏
页码:136 / 139
页数:4
相关论文
共 29 条
[1]   Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss [J].
Acciuffi, S ;
Ghosh, S ;
Ferguson, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :321-326
[2]   Incidence of juvenile-onset Crohn's disease in Scotland [J].
Armitage, E ;
Drummond, H ;
Ghosh, S ;
Ferguson, A .
LANCET, 1999, 353 (9163) :1496-1497
[3]  
BEST WR, 1976, GASTROENTEROLOGY, V70
[4]   HEMOGLOBIN IN GUT LAVAGE FLUID AS A MEASURE OF GASTROINTESTINAL BLOOD-LOSS [J].
BRYDON, WG ;
FERGUSON, A .
LANCET, 1992, 340 (8832) :1381-1382
[5]  
CHOUDARI CP, 1990, GASTROENTEROLOGY, V99, P1380
[6]   Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease [J].
Cominelli, F ;
Pizarro, TT .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 :49-53
[7]   Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease [J].
Daig, R ;
Andus, T ;
Aschenbrenner, E ;
Falk, W ;
Scholmerich, J ;
Gross, V .
GUT, 1996, 38 (02) :216-222
[8]  
Ghosh S, 2000, METH MOLEC MED, V41, P257, DOI 10.1385/1-59259-082-9:257
[9]   QUANTIFICATION OF DISEASE-ACTIVITY IN CROHNS-DISEASE BY COMPUTER-ANALYSIS OF TC-99M HEXAMETHYL PROPYLENE AMINE OXIME (HMPAO) LABELED LEUKOCYTE IMAGES [J].
GIAFFER, MH ;
TINDALE, WB ;
SENIOR, S ;
BARBER, DC ;
HOLDSWORTH, CD .
GUT, 1993, 34 (01) :68-74
[10]   RELATIONSHIP BETWEEN DISEASE-ACTIVITY INDEXES AND COLONOSCOPIC FINDINGS IN PATIENTS WITH COLONIC INFLAMMATORY BOWEL-DISEASE [J].
GOMES, P ;
DUBOULAY, C ;
SMITH, CL ;
HOLDSTOCK, G .
GUT, 1986, 27 (01) :92-95